Stephanie Harlfinger

1.4k total citations
16 papers, 952 citations indexed

About

Stephanie Harlfinger is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Stephanie Harlfinger has authored 16 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Stephanie Harlfinger's work include Pharmacogenetics and Drug Metabolism (5 papers), Receptor Mechanisms and Signaling (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Stephanie Harlfinger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Receptor Mechanisms and Signaling (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Stephanie Harlfinger collaborates with scholars based in Germany, United Kingdom and United States. Stephanie Harlfinger's co-authors include Edgar Schömig, Andreas Lazar, Dirk Gründemann, Stefan Gölz, Andreas Geerts, Norma Jung, A. Rubbert, Reinhard Berkels, Dermot F. McGinnity and Beth Williamson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Stephanie Harlfinger

13 papers receiving 928 citations

Peers

Stephanie Harlfinger
Wilhelmina I. Davis United States
Rodolfo Gasser Switzerland
Norman Huebert United States
Robert E. Stratford United States
Zhiming Wen United States
Nalini Sadagopan United States
Rita A. Halpin United States
Paul Weller United States
Jocelyn Yabut United States
John Skoko United States
Wilhelmina I. Davis United States
Stephanie Harlfinger
Citations per year, relative to Stephanie Harlfinger Stephanie Harlfinger (= 1×) peers Wilhelmina I. Davis

Countries citing papers authored by Stephanie Harlfinger

Since Specialization
Citations

This map shows the geographic impact of Stephanie Harlfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Harlfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Harlfinger more than expected).

Fields of papers citing papers by Stephanie Harlfinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Harlfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Harlfinger. The network helps show where Stephanie Harlfinger may publish in the future.

Co-authorship network of co-authors of Stephanie Harlfinger

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Harlfinger. A scholar is included among the top collaborators of Stephanie Harlfinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Harlfinger. Stephanie Harlfinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bapiro, Tashinga E., Scott Martin, Thomas S. Blacker, et al.. (2025). A mismatch in enzyme-redox partnerships underlies divergent cytochrome P450 activities between human hepatocytes and microsomes. Communications Biology. 8(1). 1539–1539.
2.
Foster, Alison J., Stephanie Harlfinger, G. Smith, et al.. (2025). Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidates. Toxicology Research. 14(3). tfaf054–tfaf054.
4.
Bapiro, Tashinga E., et al.. (2023). The Disconnect in Intrinsic Clearance Determined in Human Hepatocytes and Liver Microsomes Results from Divergent Cytochrome P450 Activities. Drug Metabolism and Disposition. 51(7). 892–901. 6 indexed citations
5.
Colclough, Nicola, Ravindra V. Alluri, Danxi Li, et al.. (2023). Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier. Drug Metabolism and Disposition. 52(2). 95–105. 10 indexed citations
6.
Williamson, Beth, Stephanie Harlfinger, & Dermot F. McGinnity. (2020). Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance. Drug Metabolism and Disposition. 48(11). 1137–1146. 30 indexed citations
7.
Pike, Andy, Beth Williamson, Stephanie Harlfinger, Scott Martin, & Dermot F. McGinnity. (2020). Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective. Drug Discovery Today. 25(10). 1793–1800. 155 indexed citations
8.
Velcicky, Juraj, Rainer Wilcken, Simona Cotesta, et al.. (2020). Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure. Journal of Medicinal Chemistry. 63(17). 9856–9875. 24 indexed citations
9.
Metcalf, Chester A., Sönke Svenson, Jungyeon Hwang, et al.. (2019). Discovery of a Novel Cabazitaxel Nanoparticle–Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin–PEG Copolymer Based Delivery Platform. Journal of Medicinal Chemistry. 62(21). 9541–9559. 7 indexed citations
10.
Schunk, Stefan, Klaus Linz, Claudia Hinze, et al.. (2014). Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists. ACS Medicinal Chemistry Letters. 5(8). 851–856. 29 indexed citations
11.
Gabrielsson, Johan, Stephan Hjorth, Barbara Vogg, et al.. (2014). Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples. European Journal of Pharmaceutical Sciences. 67. 144–159. 9 indexed citations
12.
Schunk, Stefan, Klaus Linz, Claudia Hinze, et al.. (2014). Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol. ACS Medicinal Chemistry Letters. 5(8). 857–862. 75 indexed citations
13.
Harlfinger, Stephanie, Stefan Gölz, Andreas Geerts, et al.. (2007). Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochemical Pharmacology. 74(2). 309–316. 63 indexed citations
14.
Schreiber, Daniela, Stephanie Harlfinger, C.W. Gerth, et al.. (2006). Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. Analytical Biochemistry. 361(2). 162–168. 56 indexed citations
15.
Harlfinger, Stephanie, Christian Fork, Andreas Lazar, Edgar Schömig, & Dirk Gründemann. (2005). Are organic cation transporters capable of transporting prostaglandins?. Naunyn-Schmiedeberg s Archives of Pharmacology. 372(2). 125–130. 18 indexed citations
16.
Gründemann, Dirk, Stephanie Harlfinger, Stefan Gölz, et al.. (2005). Discovery of the ergothioneine transporter. Proceedings of the National Academy of Sciences. 102(14). 5256–5261. 470 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026